Literature DB >> 28108813

Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.

Feifei Si1,2, Yao Wu1,2, Fang Gao1,2, Siqi Feng1,2, Ruixi Liu3, Qijian Yi4.   

Abstract

Kawasaki disease (KD) arises due to the disorder of the inflammation response and faulty immune regulation. Interleukin-27 (IL-27) is a novel cytokine with both pro-inflammatory and anti-inflammatory effects. This study investigated the relationship between serum levels of IL-27, Interleukin-17A (IL-17A), Interleukin-10 (IL-10), Interleukin-6 (IL-6), Interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and coronary artery lesions (CALs) in patients with KD. We obtained blood samples from 81 children with KD before intravenous immunoglobulin (IVIG) therapy. Levels of IL-27, IL-17A, IL-10, IL-6, IL-1β and TNF-α were measured in 251 cases, including 4 groups: the normal control group, NC (n = 90), febrile control, FC (n = 80), KD without coronary arteries (n = 41) and KD with coronary arterial lesions (n = 40). White blood cells counts (WBC), red blood cells counts (RBC), hemoglobin, C-reactive protein (CRP), erythrocyte sedimentation rate and procalcitonin (PCT) were tested in all subjects. Levels of IL-27, IL-10, IL-17A, IL-6, IL-1β and TNF-α were significantly elevated, and RBC and hemoglobin significantly decreased in the group of KD group compared with febrile and control groups. IL-27, IL-6, IL-1β and TNF-α serum levels are even higher in KD children with CALs. There was positive relationship between serum levels of IL-27 and WBC, CRP, PCT, IL-10, IL-17A, IL-6 and TNF-α in children with KD. The up-regulation of IL-27 may be closely linked to up-regulation of systemic pro-inflammatory markers in acute KD. Morover, IL-27 may be involved in the development of CALs in acute KD.

Entities:  

Keywords:  Coronary arterial lesion; Interleukin-10 (IL-10); Interleukin-17A (IL-17A); Interleukin-27 (IL-27); Kawasaki disease (KD)

Mesh:

Substances:

Year:  2017        PMID: 28108813     DOI: 10.1007/s10238-017-0451-8

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  43 in total

1.  Intravenous gamma-globulin therapy improves hypercytokinemia in the acute phase of Kawasaki disease.

Authors:  Naoki Kobayashi; Masaaki Mori; Yoshinori Kobayashi; Takako Miyamae; Tomoyuki Imagawa; Toshiya Okuyama; Hiroko Kurozumi; Shumpei Yokota
Journal:  Mod Rheumatol       Date:  2004-12       Impact factor: 3.023

Review 2.  Kawasaki Disease.

Authors:  Jane W Newburger; Masato Takahashi; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2016-04-12       Impact factor: 24.094

3.  High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease.

Authors:  J Hirao; S Hibi; T Andoh; T Ichimura
Journal:  Int Arch Allergy Immunol       Date:  1997-02       Impact factor: 2.749

4.  Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin.

Authors:  Mohan S Maddur; Janakiraman Vani; Pushpa Hegde; Sebastien Lacroix-Desmazes; Srini V Kaveri; Jagadeesh Bayry
Journal:  J Allergy Clin Immunol       Date:  2011-02-01       Impact factor: 10.793

5.  Molecular and immunological biomarkers to predict IVIg response.

Authors:  Caroline Galeotti; Srini V Kaveri; Jagadeesh Bayry
Journal:  Trends Mol Med       Date:  2015-02-10       Impact factor: 11.951

6.  Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations.

Authors:  Mohan S Maddur; Meenu Sharma; Pushpa Hegde; Sébastien Lacroix-Desmazes; Srini V Kaveri; Jagadeesh Bayry
Journal:  J Clin Immunol       Date:  2012-08-07       Impact factor: 8.317

7.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

8.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

9.  Oxidative stress and defective platelet apoptosis in naïve patients with Kawasaki disease.

Authors:  Elisabetta Straface; Lucrezia Gambardella; Alessio Metere; Alessandra Marchesi; Giuseppe Palumbo; Elisabetta Cortis; Alberto Villani; Donatella Pietraforte; Marina Viora; Walter Malorni; Domenico Del Principe
Journal:  Biochem Biophys Res Commun       Date:  2010-01-15       Impact factor: 3.575

Review 10.  Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells.

Authors:  B Afzali; P Mitchell; R I Lechler; S John; G Lombardi
Journal:  Clin Exp Immunol       Date:  2009-11-11       Impact factor: 4.330

View more
  7 in total

1.  Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.

Authors:  Siqi Feng; Ya Su; Li Luo; Fengchuan Jing; Qijian Yi
Journal:  Pediatr Res       Date:  2018-05-09       Impact factor: 3.756

2.  Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.

Authors:  Yue Peng; Qiongfei Pei; Siqi Feng; Ya Su; Ruixi Liu; Qijian Yi; Pengfei Guo
Journal:  Clin Exp Med       Date:  2019-09-03       Impact factor: 3.984

3.  Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities.

Authors:  Goshgar Mammadov; Hui Hui Liu; Wei Xia Chen; Guo Zhen Fan; Rui Xue Li; Fei Fei Liu; Sama Samadli; Jing Jing Wang; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Wei Wei; Peng Hu
Journal:  Clin Exp Med       Date:  2019-11-16       Impact factor: 3.984

4.  A new scoring system for coronary artery abnormalities in Kawasaki disease.

Authors:  Hui Hui Liu; Wei Xia Chen; Man Man Niu; Qi Jiang; Zhen Qiu; Guo Zhen Fan; Rui Xue Li; Goshgar Mammadov; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Peng Hu
Journal:  Pediatr Res       Date:  2021-09-28       Impact factor: 3.953

5.  Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance.

Authors:  Lin Zhang; Junfeng Zhang; Shaohong Su; Suyan Luo
Journal:  PeerJ       Date:  2019-01-04       Impact factor: 2.984

6.  The Relationship between Retinol-Binding Protein 4 and Markers of Inflammation and Thrombogenesis in Children with Kawasaki Disease.

Authors:  Maoling Yang; Haobo Weng; Qiongfei Pei; Fengchuan Jing; Qijian Yi
Journal:  Mediators Inflamm       Date:  2021-01-11       Impact factor: 4.529

7.  Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease.

Authors:  Li Ming; Hui-Ling Cao; Qiushu Li; Gengsheng Yu
Journal:  Pediatr Cardiol       Date:  2021-05-25       Impact factor: 1.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.